Analytical & Formulation
Development to Ensure ADC Quality and Stability
Xcellon Biologics provides Analytical & Formulation Development services tailored to the complexity of ADCs and bioconjugates. Our integrated approach leverages platform DSP purification to minimize free payloads and impurities, while comprehensive formulation and stability assessments confirm performance under real-world conditions. These capabilities serve as the critical checkpoints that validate product attributes and support smooth regulatory submissions.
What’s at Stake Without Robust Analytics and Formulation
What We Offer
- Identity & structural analysis
- Purity & impurity analysis
- Potency testing
- Stability testing
- Compendial testing
- Safety & general testing
- High throughput formulation development
Capabilities
- Agilent Q-TOF LCMS
- Agilent HPLC
- Waters UPLC
- Protein Simple Maurice
- Repligen Solo VPE
- Sartorius Octet
- Thermo Fisher PCR systems
- Agilent Synergy Neo plate reader
- Unchained Labs Uncle
Analytical development services validate early candidates from ADC lead selection and confirm conjugate quality during ADC development workflows. Our formulation strategies directly support bioprocess development by ensuring scalability and stability, and provide release criteria for future GMP manufacturing.
Confirm the quality attributes of your ADCs with confidence
FAQs for Advanced Analytics & Formulation
ADC programs frequently struggle with detecting and quantifying trace levels of free payload and degradation products. Our integrated analytical development workflows, combined with our platform DSP process, are designed to identify and control these risks early, ensuring cleaner profiles and fewer surprises during scale-up or regulatory review.